JP2021503301A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021503301A5 JP2021503301A5 JP2020545051A JP2020545051A JP2021503301A5 JP 2021503301 A5 JP2021503301 A5 JP 2021503301A5 JP 2020545051 A JP2020545051 A JP 2020545051A JP 2020545051 A JP2020545051 A JP 2020545051A JP 2021503301 A5 JP2021503301 A5 JP 2021503301A5
- Authority
- JP
- Japan
- Prior art keywords
- aspects
- placenta
- composition according
- exosome
- hsa
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023183102A JP2024023185A (ja) | 2017-11-16 | 2023-10-25 | エキソソームを単離するための胎盤の培養 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762587335P | 2017-11-16 | 2017-11-16 | |
| US62/587,335 | 2017-11-16 | ||
| PCT/US2018/061697 WO2019099955A1 (en) | 2017-11-16 | 2018-11-16 | Cultivation of placenta to isolate exosomes |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023183102A Division JP2024023185A (ja) | 2017-11-16 | 2023-10-25 | エキソソームを単離するための胎盤の培養 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021503301A JP2021503301A (ja) | 2021-02-12 |
| JP2021503301A5 true JP2021503301A5 (enExample) | 2022-01-04 |
Family
ID=65279618
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020545051A Pending JP2021503301A (ja) | 2017-11-16 | 2018-11-16 | エキソソームを単離するための胎盤の培養 |
| JP2023183102A Pending JP2024023185A (ja) | 2017-11-16 | 2023-10-25 | エキソソームを単離するための胎盤の培養 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023183102A Pending JP2024023185A (ja) | 2017-11-16 | 2023-10-25 | エキソソームを単離するための胎盤の培養 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20190307686A1 (enExample) |
| EP (1) | EP3710575A1 (enExample) |
| JP (2) | JP2021503301A (enExample) |
| KR (1) | KR20200083596A (enExample) |
| CN (2) | CN111433352A (enExample) |
| AU (1) | AU2018370157A1 (enExample) |
| CA (1) | CA3082880A1 (enExample) |
| EA (1) | EA202091219A1 (enExample) |
| MA (1) | MA51649A (enExample) |
| MX (1) | MX2020005100A (enExample) |
| PH (1) | PH12020550660A1 (enExample) |
| SG (1) | SG11202004523SA (enExample) |
| WO (1) | WO2019099955A1 (enExample) |
| ZA (1) | ZA202002775B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3801028A4 (en) | 2018-05-30 | 2022-04-13 | Direct Biologics LLC | A growth factor and extracellular vesicle frozen or powdered additive comprising a mesenchymal stem cell (msc) preparation and methods of use |
| US12569517B2 (en) | 2019-02-07 | 2026-03-10 | Direct Biologics, Llc | Method for treating osteoarthritis with mesenchymal stem cell exosomes |
| CA3142020A1 (en) * | 2019-06-19 | 2020-12-24 | Celularity Inc. | Exosomes for disease treatment |
| US12213995B2 (en) | 2019-07-18 | 2025-02-04 | Direct Biologics, Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| EP4065690A4 (en) | 2019-11-29 | 2022-10-05 | Rutgers, the State University of New Jersey | METHODS OF ISOLATING UMBRELLA PLASMA PRODUCTS, TISSUE AND CELL EXOSOMES AND COMPOSITIONS AND METHODS OF USE THEREOF |
| KR102615824B1 (ko) * | 2020-03-18 | 2023-12-21 | 가톨릭대학교 산학협력단 | 제대혈 혈장 엑소좀 모방체 제작 및 이의 상처치료 용도 |
| EP4136456A1 (en) * | 2020-04-17 | 2023-02-22 | Therawis Diagnostics GmbH | Method for enriching exosomes |
| KR20230004709A (ko) * | 2020-04-22 | 2023-01-06 | 다이렉트 바이오로직스 엘엘씨 | 감염성 질환과 연관된 염증성 병태를 치료하기 위한 방법 및 조성물 |
| US20230183809A1 (en) * | 2020-04-22 | 2023-06-15 | Exostem Biotec Ltd. | Extracellular vesicles for treatment and diagnosis |
| KR102317052B1 (ko) * | 2020-05-04 | 2021-10-25 | 주식회사 티에스셀바이오 | 태반 유래의 세포외 소포의 항염증 항바이러스 효과 조성물 |
| TW202146034A (zh) * | 2020-05-05 | 2021-12-16 | 美國商加速生物科學有限公司 | 包含有分泌蛋白體的藥學與化妝品組成物 |
| WO2021235176A1 (ja) * | 2020-05-22 | 2021-11-25 | 学校法人麻布獣医学園 | アレルゲン不活化剤の評価方法及びアレルゲン不活化剤の評価キット |
| KR102316777B1 (ko) * | 2020-06-26 | 2021-10-25 | 주식회사 씨케이엑소젠 | 엑소좀 생산 조절 세포, 이를 포함하는 조성물, 이로부터 얻은 엑소좀 및 엑소좀 생산 방법 |
| US20230248773A1 (en) * | 2020-07-09 | 2023-08-10 | Exo Biologics Sa | Extracellular Vesicles and Compositions Thereof |
| CN112903999A (zh) * | 2021-01-20 | 2021-06-04 | 蚌埠医学院第一附属医院（蚌埠医学院附属肿瘤医院） | 一种用于纳米流式细胞仪检测的外泌体的制备方法及应用 |
| US12226438B2 (en) * | 2021-06-18 | 2025-02-18 | Hilltop BioSciences, Inc. | System and method for therapeutic compositions from a plurality of different birth tissues and exosomes |
| CN113633758B (zh) * | 2021-07-29 | 2025-06-17 | 复旦大学附属肿瘤医院 | 一种负载膜结合型肿瘤坏死因子相关凋亡诱导配体和小分子抗肿瘤药物的复合外泌体 |
| JP7044429B1 (ja) * | 2021-12-20 | 2022-03-30 | 株式会社 バイオミメティクスシンパシーズ | 腫瘍を縮小、又は消失させるための組成物 |
| CN121013983A (zh) | 2023-04-25 | 2025-11-25 | 瑟拉维斯诊断有限责任公司 | 用于检测和定量外泌体的方法 |
| CN117987350B (zh) * | 2024-04-03 | 2024-06-21 | 优智嘉(天津)生物科技有限公司 | 一种人胎盘绒毛外泌体快速提取试剂盒、提取方法、胎盘外泌体及应用 |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
| CN119842608B (zh) * | 2025-03-18 | 2025-07-22 | 博雅干细胞科技有限公司细胞科技分公司 | 一种提高脐带血来源nk细胞杀伤力的方法及其应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2687219A1 (en) * | 2012-07-18 | 2014-01-22 | Universität Duisburg-Essen | Use of preparations comprising exosomes derived from mesenchymal stem cells (MSCs) in the prevention and therapy of inflammatory conditions |
| WO2016057755A1 (en) * | 2014-10-09 | 2016-04-14 | Anthrogenesis Corporation | Placenta-derived adherent cell exosomes and uses thereof |
| CN106282107A (zh) * | 2016-08-30 | 2017-01-04 | 章毅 | 人胎盘间充质干细胞源分离外泌体的方法及其应用 |
-
2018
- 2018-11-16 MX MX2020005100A patent/MX2020005100A/es unknown
- 2018-11-16 SG SG11202004523SA patent/SG11202004523SA/en unknown
- 2018-11-16 CN CN201880079103.8A patent/CN111433352A/zh active Pending
- 2018-11-16 EA EA202091219A patent/EA202091219A1/ru unknown
- 2018-11-16 JP JP2020545051A patent/JP2021503301A/ja active Pending
- 2018-11-16 AU AU2018370157A patent/AU2018370157A1/en not_active Abandoned
- 2018-11-16 US US16/194,278 patent/US20190307686A1/en not_active Abandoned
- 2018-11-16 MA MA051649A patent/MA51649A/fr unknown
- 2018-11-16 EP EP18845327.8A patent/EP3710575A1/en active Pending
- 2018-11-16 WO PCT/US2018/061697 patent/WO2019099955A1/en not_active Ceased
- 2018-11-16 KR KR1020207016887A patent/KR20200083596A/ko not_active Ceased
- 2018-11-16 CN CN202411177421.1A patent/CN119552810A/zh active Pending
- 2018-11-16 CA CA3082880A patent/CA3082880A1/en active Pending
-
2020
- 2020-05-14 ZA ZA2020/02775A patent/ZA202002775B/en unknown
- 2020-05-15 PH PH12020550660A patent/PH12020550660A1/en unknown
-
2023
- 2023-06-02 US US18/205,303 patent/US20230310319A1/en not_active Abandoned
- 2023-10-25 JP JP2023183102A patent/JP2024023185A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021503301A5 (enExample) | ||
| AU2020204267B2 (en) | Compositions and methods for immune cell modulation in adoptive immunotherapies | |
| Noort et al. | Mesenchymal stem cells promote engraftment of human umbilical cord blood–derived CD34+ cells in NOD/SCID mice | |
| Finke et al. | Characterization of a human renal cell carcinoma specific cytotoxic CD8+ T cell line | |
| Štach et al. | Inducible secretion of IL-21 augments anti-tumor activity of piggyBac-manufactured chimeric antigen receptor T cells | |
| EP3307875B1 (en) | Methods for the production of tcr gamma delta+ t cells | |
| JP2021503301A (ja) | エキソソームを単離するための胎盤の培養 | |
| JP2022130607A (ja) | 養子免疫療法における免疫細胞調節のための組成物および方法 | |
| JP2020172522A (ja) | ガンマデルタｔ細胞およびその使用 | |
| Finke et al. | Characterization of the cytolytic activity of CD4+ and CD8+ tumor-infiltrating lymphocytes in human renal cell carcinoma | |
| Najar et al. | Bone marrow mesenchymal stromal cells induce proliferative, cytokinic and molecular changes during the T cell response: the importance of the IL-10/CD210 axis | |
| CN110914410A (zh) | γδT细胞扩增、组合物及其使用方法 | |
| JP7668781B2 (ja) | 幹細胞培養及び幹細胞治療用プライム化培地及びプライム化方法 | |
| JP5937003B2 (ja) | 免疫介在性疾患における臨床応用のための、抑制機能の高められた制御性ｔ細胞のエクスビボ増加方法 | |
| Kellner et al. | Differential properties of human stromal cells from bone marrow, adipose, liver and cardiac tissues | |
| EP3350316A1 (en) | Improved method for ex vivo expansion cd34+hspcs into nk cells using an aryl hydrocarbon receptor antagonist | |
| Peragine et al. | Immunophenotypic and functional characterization of ex vivo expanded natural killer cells for clinical use in acute lymphoblastic leukemia patients | |
| Alexander et al. | Til from renal‐cell carcinoma: Restimulation with tumor influences proliferation and cytolytic activity | |
| Wuchter et al. | Plerixafor induces the rapid and transient release of stromal cell-derived factor-1 alpha from human mesenchymal stromal cells and influences the migration behavior of human hematopoietic progenitor cells | |
| EP1127107B1 (en) | Methods for the production of tcr gamma delta t cells | |
| Hatzfeld et al. | A sub-population of high proliferative potential-quiescent human mesenchymal stem cells is under the reversible control of interferon α/β | |
| EP1268746B1 (en) | PRODUCTION OF TcR GAMMA DELTA T CELLS | |
| CN103540566A (zh) | 用于长期造血种群恢复的方法和组合物 | |
| AU2001248162A1 (en) | Production of TcR gamma delta T cells | |
| WO2009021995A1 (de) | Verfahren zur in-vitro-amplifikation von regulatorischen t-zellen |